Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
- Publication date
- 31 August 2021
- Publisher
- 'American Society of Clinical Oncology (ASCO)'